Suppression of FADS1 induces ROS generation, cell cycle arrest, and apoptosis in melanocytes: implications for vitiligo
Related Experiment Video
Updated: Jan 1, 2026

Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Published on: August 27, 2021
Luyan Tang1, Jian Li1, Wenwen Fu1
1Department of Dermatology, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, China.
Abstract:
Vitiligo is a potentially serious condition characterized by loss of melanin and death of melanocytes. To identify potential therapeutic targets for vitiligo, we conducted a microarray analysis of three human vitiligo specimens and paired adjacent normal tissues. Because we found that the fatty acid desaturase 1 (FADS1) gene was downregulated in vitiligo specimens, we carried out experiments to assess its role in melanocyte replication and survival. RT-qPCR was used to verify that FADS1 expression was lower in vitiligo-affected tissues and vitiligo melanocyte PIG3V cells than in matched controls or normal human epidermal PIG1 melanocytes. In addition, CCK-8, immunofluorescence, western blot and flow cytometry assay were used to detect the proliferation and apoptosis in PIG1 cells respectively. Overexpression of FADS1 promoted proliferation of PIG3V melanocytes, while FADS1 silencing inhibited proliferation and induced cell death in PIG1 melanocytes. Increased ROS generation; induction of mitochondrial-mediated apoptosis via upregulation of Bax and active caspases 3 and 9 and downregulation of Bcl-2; and cell cycle arrest via downregulation of c-Myc and Cyclin D1 and upregulation of p21 were all enhanced after FADS1 silencing in PIG1 melanocytes. These findings implicate FADS1 downregulation in the pathogenesis of vitiligo and may open new avenues for its treatment.
Insights
Downregulation of the fatty acid desaturase 1 (FADS1) gene contributes to vitiligo by impairing melanocyte survival and proliferation. Restoring FADS1 may offer a novel therapeutic strategy for vitiligo treatment.
Area of Science:
- Dermatology
- Molecular Biology
- Genetics
Background:
- Vitiligo is a skin condition involving melanocyte loss.
- Identifying novel therapeutic targets for vitiligo is crucial.
Purpose of the Study:
- To investigate the role of fatty acid desaturase 1 (FADS1) in vitiligo pathogenesis.
- To explore FADS1 as a potential therapeutic target for vitiligo.
Main Methods:
- Microarray analysis of vitiligo tissues and paired normal tissues.
- RT-qPCR to quantify FADS1 expression in vitiligo and normal melanocytes.
- Cellular assays (CCK-8, immunofluorescence, western blot, flow cytometry) to assess melanocyte proliferation and apoptosis.
Main Results:
- FADS1 gene was significantly downregulated in vitiligo specimens.
- FADS1 overexpression promoted vitiligo melanocyte proliferation.
- FADS1 silencing inhibited normal melanocyte proliferation and induced apoptosis, increased ROS, and cell cycle arrest.
Conclusions:
- FADS1 downregulation is implicated in vitiligo pathogenesis.
- FADS1 plays a critical role in melanocyte replication and survival.
- Targeting FADS1 may represent a new therapeutic avenue for vitiligo.
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
iPS Cell Differentiation

